A tumultuous week for biotechs

Hillary Clinton, the Democratic front runner in the race for the White House, pledged this week to crack down on the growing cost of prescription drugs and out of pocket medical expenses in the United States after Turing Pharmaceuticals announced that it was hiking the price of the drug Daraprim from $13.50 to $750 a pill. Aimee Keane asks David Crow about the sharp falls in biotech stocks that followed and whether plans such as Mrs Clinton's will end price-gouging.Music: "Starday" by Podington Bear.

Hosted on Acast. See acast.com/privacy for more information.

More from FT News in Focus

  1. 17:59Introducing: The Rachman ReviewMar 25, 2020
  2. 10:56Republican $1tn plan, Paul Tucker on damage limitsMar 20, 2020
  3. 07:56Rana Foroohar on the trillion dollar fightback, Biden sweepMar 18, 2020
  4. 09:04World on lockdown, markets melt, hospitals sufferMar 17, 2020
  5. 08:18Introducing the FT News Briefing: Fed cuts to zero, airport pinch, hand sanitiser saleMar 16, 2020
  6. 16:04Persecution of China's Uighur Muslims exposedMar 11, 2020
  7. 14:40Will coronavirus cause a global recession?Mar 09, 2020
  8. 13:52Secrets of the South PoleMar 04, 2020
  9. 13:52Is India becoming a Big Brother state?Mar 02, 2020
  10. 17:14Is Trump abusing his power over the judiciary?Feb 26, 2020